229 filings
8-K
HROW
Harrow Inc
21 Mar 24
Other Events
8:46am
8-K
HROW
Harrow Inc
20 Mar 24
Other Events
7:04am
8-K
HROW
Harrow Inc
19 Mar 24
Harrow Announces Fourth Quarter and Year-End 2023 Financial Results
5:26pm
8-K
HROW
Harrow Inc
15 Feb 24
Harrow Licenses Canadian Rights to Apotex For Five Branded Ophthalmic Pharmaceutical Products
4:15pm
8-K
HROW
Harrow Inc
29 Jan 24
Harrow Announces New Appointments to its Board of Directors
4:30pm
8-K
xov22c69
3 Jan 24
Melt Pharmaceuticals Provides Corporate Update
8:00am
8-K
7pqn3lzh rfm63i8iim
13 Nov 23
Harrow Announces Third Quarter 2023 Financial Results
4:34pm
8-K
7r1599
3 Nov 23
Departure of Directors or Certain Officers
4:52pm
8-K
1ee4 v23vhj
29 Sep 23
Amendments to Articles of Incorporation or Bylaws
4:01pm
8-K
01oe7 ht0slea
9 Aug 23
Harrow Announces Second Quarter 2023 Financial Results
4:05pm
8-K
xx8 b2ul7r
21 Jul 23
Harrow Prices $60 Million Public Offering of Common Stock
4:02pm
8-K
7z35o4 p2va0tofb
18 Jul 23
Harrow Provides Select Preliminary Second Quarter 2023 Financial Guidance
4:59pm
8-K
bo5tyn5z
23 Jun 23
Submission of Matters to a Vote of Security Holders
4:25pm
8-K
mse2hy8hyxzd
11 May 23
Harrow Announces First Quarter 2023 Financial Results
4:15pm
8-K
8vzbdm2hj7cw7m0m
28 Mar 23
Harrow Announces New $100 Million Secured Credit Facility with Oaktree
4:32pm
8-K
21zvr
23 Mar 23
Harrow Announces Fourth Quarter and Year-End 2022 Financial Results
4:45pm
8-K
yy1j2o chc26e475
23 Jan 23
Completion of Acquisition or Disposition of Assets
7:20am
8-K
5gyev
12 Jan 23
Other Events
4:05pm
8-K
evpodt bwkxj
20 Dec 22
Entry into a Material Definitive Agreement
4:45pm
8-K
jo6kmk5ctio51cj08n47
16 Dec 22
Harrow Secures Capital to Close Recently Announced Acquisition
4:40pm